Product Liability

Juul E-Cigarette Marketing to Minors Litigation

Juul E-Cigarette Marketing to Minors Litigation — Product Liability class action lawsuit

Case Overview

Consolidated in the Northern District of California in 2019, this massive multidistrict litigation brings together thousands of claims from school districts, local governments, state attorneys general, and individual users against Juul Labs, the maker of the once-dominant e-cigarette device. Plaintiffs allege that Juul conducted a systematic and deceptive marketing campaign — using social media influencers, youth-oriented imagery, and appealing flavors — that was specifically designed to hook underage consumers on nicotine. Internal company documents produced in discovery revealed executives were aware that a significant portion of their user base was under 18, yet continued to pursue aggressive youth-targeted strategies. School districts argue they were forced to divert substantial resources to combat vaping on campuses, fund addiction counseling, and install vaping detection equipment.

Juul has reached settlements exceeding $1.7 billion with dozens of states and thousands of school districts since 2022, including a landmark $438.5 million multistate settlement in 2022. In 2024, Juul agreed to a $150 million settlement with a second wave of school districts, with individual personal injury cases — particularly those involving young people diagnosed with nicotine addiction, lung injury (EVALI), or seizures — continuing to advance through the MDL. Juul's parent company Altria, which paid $12.8 billion for a 35% stake in Juul in 2018, has faced separate but related litigation over its role in enabling the youth marketing scheme. Individual bellwether trials have produced mixed results, keeping pressure on both defendants to resolve remaining claims.

Who May Qualify

Individuals (particularly those under 25) who used Juul products and were subsequently diagnosed with nicotine addiction, lung injury (EVALI), seizures, or other serious health conditions; parents of minors harmed; school districts and municipalities that incurred costs combating youth vaping. Strongest claims involve use that began before age 18.

Frequently Asked Questions

Can I sue Juul Labs for marketing e-cigarettes to minors?

Yes, if you or a minor in your family used Juul products and suffered health injuries like nicotine addiction, lung damage, or seizures, you may be eligible to join the class action lawsuit against Juul Labs. The company has already settled for over $1.7 billion due to allegations that it deliberately targeted youth through deceptive marketing campaigns.

How do I get money from the Juul settlement?

To claim compensation from the Juul settlement, you'll need to file a claim demonstrating that you or your child used Juul products and developed health conditions like nicotine addiction or lung injury. Deadlines vary by jurisdiction and claim type, so you should act quickly and consult with the settlement administrator or your attorney for specific filing instructions.

Who is eligible for the Juul class action settlement?

The settlement covers individuals under 25 who used Juul products and developed nicotine addiction or serious health conditions, parents of harmed minors, and school districts that incurred costs addressing youth vaping. Claims are strongest for those who began using Juul before age 18.

Related Cases

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action — Product Liability class action lawsuit

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action

Current
Product Liability
Class action lawsuit alleging that Ozempic, Wegovy, and other GLP-1 weight loss drugs are linked to NAION (non-arteritic anterior ischemic optic neuropathy), a serious condition causing sudden vision loss in users.
Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation — Product Liability class action lawsuit

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation

Current
Product Liability
Women who received long-term Depo-Provera (injectable contraceptive) injections are suing Pfizer, alleging the drug significantly increases the risk of developing meningioma brain tumors and that the company failed to warn patients and physicians of this risk despite knowing about it for years.
Tesla Cybertruck Recall & Products Liability Class Action — Product Liability class action lawsuit

Tesla Cybertruck Recall & Products Liability Class Action

Current
Product Liability
Tesla Cybertruck owners filed a class action alleging that the vehicle suffers from dangerous defects — including an accelerator pedal that can get physically trapped and cause unintended full-throttle acceleration — that Tesla knew about before delivery but failed to disclose. The lawsuit follows multiple NHTSA investigations and a major safety recall.